Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma

Table 1 Expression levels of HSD17B6 in different datasets

HCCDB ID	Source ID	P-value	Type	Sample numbers	Mean (log2)	STD (log2)
HCCDB1	GSE22058	7.25E−10	HCC	100	12.05	1.417
HCCDB1	GSE22058	7.25E−10	Adjacent	97	13.02	0.232
HCCDB3	GSE25097	1.25E−27	HCC	268	9.786	5.504
			Adjacent	243	14.37	3.136
			Cirrhotic	40	9.1	5.075
			Healthy	6	14.72	1.735
HCCDB4	GSE36376	5.71E−23	HCC	240	10.51	2.007
HCCDB4	GSE36376	5.71E−23	Adjacent	193	12.15	1.215
HCCDB6	GSE14520(GPL3721 Subset)	2.22E−27	HCC	225	9.463	2.176
HCCDB6	GSE14520(GPL3721 Subset)	2.22E−27	Adjacent	220	11.3	0.6076
HCCDB7	GSE10143	0.0007743	HCC	80	13.39	1.008
HCCDB7	GSE10143	0.0007743	Adjacent	82	13.83	0.4873
HCCDB11	GSE46444	0.01807	HCC	88	10.4	2.483
HCCDB11	GSE46444	0.01807	Adjacent	48	11.33	1.949
HCCDB12	GSE54236	0.0005134	HCC	81	14.68	1.592
HCCDB12	GSE54236	0.0005134	Adjacent	80	15.37	0.6459
HCCDB16	GSE64041	0.003082	HCC	60	11.44	1.295
HCCDB16	GSE64041	0.003082	Adjacent	60	12.05	0.866
HCCDB17	GSE76427	0.07784	HCC	115	12.45	2.032
HCCDB17	GSE76427	0.07784	Adjacent	52	12.86	0.9313
HCCDB18	ICGC-LIRI-JP	4.57E−15	HCC	212	7.193	1.683
HCCDB18	ICGC-LIRI-JP	4.57E−15	Adjacent	177	8.275	0.8307

ISSN: 1475-2867